![Zhang Xiuping](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zhang Xiuping
Directeur/Membre du Conseil chez BIOSENSORS INTERNATIONAL GROUP LTD
Postes actifs de Zhang Xiuping
Sociétés | Poste | Début | Fin |
---|---|---|---|
BIOSENSORS INTERNATIONAL GROUP LTD | Directeur/Membre du Conseil | 17/10/2014 | - |
Independent Dir/Board Member | 17/10/2014 | - | |
Moelis & Company Asia Ltd.
![]() Moelis & Company Asia Ltd. Investment ManagersFinance Part of Moelis & Co., Moelis & Company Asia Ltd. is a financial advisory services company based in Hong Kong, Hong Kong. The Chinese company was founded by Richard Orders. Zhang Xiuping has been the CEO of the company since 2013. Moelis & Company Asia was acquired by Moelis Asset Management LP on April 30, 2011. | Directeur Général | 27/09/2013 | - |
Historique de carrière de Zhang Xiuping
Formation de Zhang Xiuping
Rollins College (Florida) | Masters Business Admin |
Statistiques
Internationale
Hong Kong | 2 |
Singapour | 2 |
Etats-Unis | 2 |
Opérationnelle
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectorielle
Finance | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Moelis & Company Asia Ltd.
![]() Moelis & Company Asia Ltd. Investment ManagersFinance Part of Moelis & Co., Moelis & Company Asia Ltd. is a financial advisory services company based in Hong Kong, Hong Kong. The Chinese company was founded by Richard Orders. Zhang Xiuping has been the CEO of the company since 2013. Moelis & Company Asia was acquired by Moelis Asset Management LP on April 30, 2011. | Finance |
Biosensors International Group Ltd.
![]() Biosensors International Group Ltd. Medical SpecialtiesHealth Technology Biosensors International Group Ltd. develops, manufactures, and markets medical devices for interventional cardiology and critical care procedures. It operates through the following segments: Interventional Cardiology, Critical Care, Cardiac Diagnostic, and Licensing Revenue. The company was founded in 1990 by Yoh Chie Lu and is headquartered in Singapore. | Health Technology |
- Bourse
- Insiders
- Zhang Xiuping
- Expérience